Interactions between pharmaceutical representatives and doctors in training. A thematic review
about
Conflict of Interest Policies at French Medical Schools: Starting from the BottomCharacteristics and impact of drug detailing for gabapentinInformation from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic reviewTurkish Final Year Medical Students' Exposure to and Attitudes Concerning Drug Company Interactions: A Perspective from a Minimally Regulated Environment for Medical StudentsAttitudes and Relationship between Physicians and the Pharmaceutical Industry in a Public General Hospital in Lima, PeruAssociation between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysisEvidence-informed person-centered healthcare part I: do 'cognitive biases plus' at organizational levels influence quality of evidence?Student feedback about The Skeptic Doctor, a module on pharmaceutical promotionBetween government policy, clinical autonomy, and market demands: a qualitative study of the impact of the Prescribing Analysis System on behavior of physicians in South Korea.Teaching trainees to negotiate research collaborations with industry: a mentorship model.Gifts and corporate influence in doctor of pharmacy education.Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious DiseasesKnowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review.Physicians, social media, and conflict of interest.Pharmacology education in undergraduate and graduate medical education in the United States.Interactions of doctors with the pharmaceutical industryChanging interactions between physician trainees and the pharmaceutical industry: a national survey.Corporate influences on epidemiology.Professionalism perspectives among medical students of a novel medical graduate school in Malaysia.Prescribers and pharmaceutical representatives: why are we still meeting?The speakers' bureau system: a form of peer selling.Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.A study on the interactions of doctors with medical representatives of pharmaceutical companies in a Tertiary Care Teaching Hospital of South India.Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies.Interactions between physicians and pharmaceutical sales representatives in Saudi Arabia.Implementing an intensified antibiotic stewardship programme targeting daptomycin use in orthopaedic surgery: a cost-benefit analysis from the hospital perspective.Does Money Really Talk? A Resident-Driven Pay-for-Performance PilotConflicts of Interest in Medicine. A Systematic Review of Published and Scientifically evaluated CurriculaPolish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.Evaluating the reliability and accuracy of the promotional brochures for the generic pharmaceutical companies in Iraq using World Health Organization guidelines.Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.Response to "Interactions between pharmaceutical representatives and doctors in training: a thematic review".Has the hunt for conflicts of interest gone too far? No.Cognitive enhancement drug use among medical students and concerns about medical student well-being.Knowledge levels of pharmaceutical sales representatives in pain therapy: a descriptive questionnaire-based study.Structured pharmaceutical representative interactions and counterdetailing sessions as components of medical resident education.Awareness and perceptions of Vermont's prescribed product gift ban and disclosure law by prescribers and pharmacists.Dangerous liaisons: doctors-in-training and the pharmaceutical industry.Addressing within-role conflicts of interest in surgery.
P2860
Q28468374-4D212927-46A2-4EA6-9A9C-D9F68A763D38Q28469192-3549FCD7-8BE5-435F-8C24-1607868315ACQ28475841-B25E5733-F03A-4FD7-A8E0-63C338C5CF28Q28555046-B561F57E-1832-4846-9F20-382A9C277C94Q28972252-FC3A7CA7-7F9D-48C6-B984-5A78A42B233FQ29994595-0D1576BC-8A77-49B0-AA3E-A40D5E7FB35AQ30368983-E938CA3F-D507-4ED4-985D-7CE31F9ECE0FQ35649211-BD6CF151-9DA6-42F3-BF68-6FDE6E8BD533Q35782793-C00928D3-0E4E-415D-826C-A7C2D02E2D31Q35920534-153A4524-104A-485F-B30F-FD22857FD1EDQ35962581-53729A81-1795-42B9-8721-D4729431926BQ35986250-20C6DEEC-209D-4D05-AA7E-CD93D56AA8FEQ36111491-D2BFAC99-3D75-49FF-B67F-DE977C34883EQ36734055-011512EF-EA41-40C8-8695-A99EDE8359EBQ36882456-0A272D54-C41B-4CD4-B30D-3188AC31A368Q36927354-5043F5C8-C903-4423-A359-13FA41AB91B9Q37009211-835BAE64-2D7E-4FD4-88BB-A6EE69132121Q37075592-B64C3B98-3FCD-41FC-AD77-4327600AEDC3Q37138525-53D54133-23D9-4925-92D3-1E589274A96FQ37225206-3D7F1748-31B9-4FDD-9439-EECC8D3CFB66Q37393685-5B07AAC2-4419-4DE8-A2C8-F7931DCF32EBQ37613559-91C39F98-6446-4BA0-AB57-AAB1BD8D9EB3Q38625438-0C56FBF3-633B-4020-AF8A-9637C86D16A9Q38984642-789EF1F2-E050-408B-A128-CCA796DF64E9Q39063299-BC8D064E-882F-459B-83B4-B5B20AA9E4DEQ39274618-9EF3C7B3-8A97-498B-83F8-91F1CF76F730Q40422026-2E2959A4-CAA5-4524-8EAF-BAD9D1E8A61EQ41035004-15631BB9-FBA1-41FD-A277-1EBC5F40418FQ41510338-E9156438-6A80-4A9E-BDFC-130351D91DB5Q41677333-5515A39C-C4C9-4881-AFAE-D7D5748F3E9FQ42131843-05488697-662F-4151-B309-F32325C67C02Q42215595-799C8B62-F448-4971-A6E4-8FCF22221EDFQ42390920-DCCC0D1F-7F26-46E0-9C16-51CA476AA345Q43063615-6393C491-4639-4CC4-BBA0-12416F055E75Q43093442-E5733228-5965-48EA-8E71-0A09A5393597Q43565150-C30DC7F4-5773-4843-8B78-F29B97C6ACFEQ45287925-F3F1F0E5-69A4-4E1E-AB2F-C0176D92EFD2Q47273217-F3FE7F30-5420-436C-8995-2B53E179B505Q47950102-F55B70CF-7200-4A8B-90EC-8BDFB5A57EE2Q48274388-6560657D-4950-4D90-9700-9CAF36F9FA26
P2860
Interactions between pharmaceutical representatives and doctors in training. A thematic review
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Interactions between pharmaceu ...... in training. A thematic review
@ast
Interactions between pharmaceu ...... in training. A thematic review
@en
Interactions between pharmaceu ...... in training. A thematic review
@nl
type
label
Interactions between pharmaceu ...... in training. A thematic review
@ast
Interactions between pharmaceu ...... in training. A thematic review
@en
Interactions between pharmaceu ...... in training. A thematic review
@nl
prefLabel
Interactions between pharmaceu ...... in training. A thematic review
@ast
Interactions between pharmaceu ...... in training. A thematic review
@en
Interactions between pharmaceu ...... in training. A thematic review
@nl
P2860
P3181
P1476
Interactions between pharmaceu ...... in training. A thematic review
@en
P2093
Daniella A Zipkin
Michael A Steinman
P2860
P304
P3181
P356
10.1111/J.1525-1497.2005.0134.X
P407
P577
2005-08-01T00:00:00Z
P5875
P6179
1002314476